News Search

Search results for:

Ondine Accelerates COVID-19 Program

Ondine Biomedical Accelerates COVID-19 Program Ondine accelerates testing of nasal Photodisinfection against the SARS-CoV-2 novel coronavirus. Vancouver, British Columbia, Canada - May 21, 2020 Ondine Biomedical Inc. announces that it has secured funding from investors including TELUS Ventures to bring the [...]

May 21, 2020|

Rapid Elimination of Bacterium Causing Flesh-Eating Disease

Ondine Biomedical Demonstrates Rapid Elimination of Bacterium Causing Flesh-Eating Disease Photodisinfection eradicates Streptococcus pyogenes (Group A Strep), bacterium associated with Necrotizing Fasciitis Vancouver, British Columbia, Canada - May 7, 2020 Ondine Biomedical Inc., the global leader in Photodisinfection based therapies for [...]

May 7, 2020|

Ondine Targets Coronavirus Directly with Photodisinfection

Canada’s Ondine Biomedical Targets Coronavirus Directly in Nose and Nasopharynx with Photodisinfection Photodisinfection market leader launches proven antimicrobial technology into COVID-19 battle. Vancouver, British Columbia, Canada - May 5, 2020 Vancouver-based Ondine Biomedical Inc., the global leader in Photodisinfection technology, announces [...]

May 5, 2020|

Ondine Receives CE Mark for its Steriwave Nasal Photodisinfection Therapy

Ondine Biomedical Receives CE Mark for its Steriwave Nasal Photodisinfection Therapy Nasal photodisinfection has helped to significantly reduce healthcare-associated infections in Canadian hospitals and is now approved for use in the European Union Vancouver, British Columbia, Canada - May 4, 2020 [...]

May 4, 2020|

Killing microbes is not easy

Conversations That Matter: Killing microbes is not easy VANCOUVER, BC, Canada - April 10, 2020 Drug resistance is one of the top five human health threats. That’s when viruses, bacteria and fungi can no longer be killed by the drugs that [...]

April 17, 2020|

For Media Information

Simon Vane Percy

Amanda Bernard

Go to Top